fig1

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

Figure 1. ALK TKI Chemical Structure[37]. Created by BioRender.com. Authors were granted a license to use BioRender content with copyright permission. ALK: Anaplastic lymphoma kinase; TKI: tyrosine kinase inhibitor.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/